NeuroDerm

Wall Street
Biotech

Mitsubishi Tanabe buys up NeuroDerm in $1.1B deal

Mitsubishi Tanabe is to spend $1.1 billion on Parkinson’s disease biotech NeuroDerm as it looks to boost its U.S. presence and CNS pipeline.
Ben Adams Jul 24, 2017 7:19am
NeuroDerm

NeuroDerm's minipump passes the patient test

Sep 23, 2016 10:27am